ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PCSK9 Antagonists Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-34V18115
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global PCSK9 Antagonists Market Research Report 2024
BUY CHAPTERS

Global PCSK9 Antagonists Market Research Report 2024

Code: QYRE-Auto-34V18115
Report
October 2024
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Novartis
Amgen Inc
Regeneron Pharmaceuticals
Innovent Biologics
Merck
Junshi Biosciences
Akeso, Inc.
Jiangsu Hengrui Pharmaceuticals
Salubris Pharmaceuticals
Hasten Biopharmaceutical

PCSK9 Antagonists Market

PCSK9 antagonists are a class of cholesterol-lowering medications that work by blocking the activity of the PCSK9 protein, which normally degrades LDL receptors in the liver. By inhibiting PCSK9, these drugs increase the number of LDL receptors available to clear LDL cholesterol (the "bad" cholesterol) from the bloodstream, leading to significantly lower LDL-C levels. PCSK9 antagonists are often prescribed to patients who are at high risk for cardiovascular disease, particularly those who cannot achieve their target cholesterol levels with statins alone or are statin-intolerant. Common examples include alirocumab and evolocumab.
The global PCSK9 Antagonists market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for PCSK9 Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for PCSK9 Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of PCSK9 Antagonists include Sanofi, Novartis, Amgen, Regeneron Pharmaceuticals, Innovent Biologics, Merck, Hasten Biopharmaceutical, Junshi Biosciences, Akeso, Jiangsu Hengrui Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for PCSK9 Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PCSK9 Antagonists.
The PCSK9 Antagonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global PCSK9 Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PCSK9 Antagonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of PCSK9 Antagonists Market Report

Report Metric Details
Report Name PCSK9 Antagonists Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, Novartis, Amgen, Regeneron Pharmaceuticals, Innovent Biologics, Merck, Hasten Biopharmaceutical, Junshi Biosciences, Akeso, Jiangsu Hengrui Pharmaceuticals, Salubris Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of PCSK9 Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of PCSK9 Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the PCSK9 Antagonists Market report?

Ans: The main players in the PCSK9 Antagonists Market are Sanofi, Novartis, Amgen, Regeneron Pharmaceuticals, Innovent Biologics, Merck, Hasten Biopharmaceutical, Junshi Biosciences, Akeso, Jiangsu Hengrui Pharmaceuticals, Salubris Pharmaceuticals

What are the Application segmentation covered in the PCSK9 Antagonists Market report?

Ans: The Applications covered in the PCSK9 Antagonists Market report are Hypercholesterolemia, Atherosclerotic Cardiovascular Disease, Others

What are the Type segmentation covered in the PCSK9 Antagonists Market report?

Ans: The Types covered in the PCSK9 Antagonists Market report are Monoclonal Antibody, siRNA, Other

Recommended Reports

Cholesterol Management

Antagonists & Inhibitors

Targeted Cardiovascular Therapy

1 PCSK9 Antagonists Market Overview
1.1 Product Definition
1.2 PCSK9 Antagonists by Type
1.2.1 Global PCSK9 Antagonists Market Value Comparison by Type (2024-2030)
1.2.2 Monoclonal Antibody
1.2.3 siRNA
1.2.4 Other
1.3 PCSK9 Antagonists by Application
1.3.1 Global PCSK9 Antagonists Market Value by Application (2024-2030)
1.3.2 Hypercholesterolemia
1.3.3 Atherosclerotic Cardiovascular Disease
1.3.4 Others
1.4 Global PCSK9 Antagonists Market Size Estimates and Forecasts
1.4.1 Global PCSK9 Antagonists Revenue 2019-2030
1.4.2 Global PCSK9 Antagonists Sales 2019-2030
1.4.3 Global PCSK9 Antagonists Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 PCSK9 Antagonists Market Competition by Manufacturers
2.1 Global PCSK9 Antagonists Sales Market Share by Manufacturers (2019-2024)
2.2 Global PCSK9 Antagonists Revenue Market Share by Manufacturers (2019-2024)
2.3 Global PCSK9 Antagonists Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of PCSK9 Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of PCSK9 Antagonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PCSK9 Antagonists, Product Type & Application
2.7 Global Key Manufacturers of PCSK9 Antagonists, Date of Enter into This Industry
2.8 Global PCSK9 Antagonists Market Competitive Situation and Trends
2.8.1 Global PCSK9 Antagonists Market Concentration Rate
2.8.2 The Global 5 and 10 Largest PCSK9 Antagonists Players Market Share by Revenue
2.8.3 Global PCSK9 Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global PCSK9 Antagonists Market Scenario by Region
3.1 Global PCSK9 Antagonists Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global PCSK9 Antagonists Sales by Region: 2019-2030
3.2.1 Global PCSK9 Antagonists Sales by Region: 2019-2024
3.2.2 Global PCSK9 Antagonists Sales by Region: 2025-2030
3.3 Global PCSK9 Antagonists Revenue by Region: 2019-2030
3.3.1 Global PCSK9 Antagonists Revenue by Region: 2019-2024
3.3.2 Global PCSK9 Antagonists Revenue by Region: 2025-2030
3.4 North America PCSK9 Antagonists Market Facts & Figures by Country
3.4.1 North America PCSK9 Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America PCSK9 Antagonists Sales by Country (2019-2030)
3.4.3 North America PCSK9 Antagonists Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe PCSK9 Antagonists Market Facts & Figures by Country
3.5.1 Europe PCSK9 Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe PCSK9 Antagonists Sales by Country (2019-2030)
3.5.3 Europe PCSK9 Antagonists Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PCSK9 Antagonists Market Facts & Figures by Region
3.6.1 Asia Pacific PCSK9 Antagonists Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific PCSK9 Antagonists Sales by Region (2019-2030)
3.6.3 Asia Pacific PCSK9 Antagonists Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America PCSK9 Antagonists Market Facts & Figures by Country
3.7.1 Latin America PCSK9 Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America PCSK9 Antagonists Sales by Country (2019-2030)
3.7.3 Latin America PCSK9 Antagonists Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa PCSK9 Antagonists Market Facts & Figures by Country
3.8.1 Middle East and Africa PCSK9 Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa PCSK9 Antagonists Sales by Country (2019-2030)
3.8.3 Middle East and Africa PCSK9 Antagonists Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PCSK9 Antagonists Sales by Type (2019-2030)
4.1.1 Global PCSK9 Antagonists Sales by Type (2019-2024)
4.1.2 Global PCSK9 Antagonists Sales by Type (2025-2030)
4.1.3 Global PCSK9 Antagonists Sales Market Share by Type (2019-2030)
4.2 Global PCSK9 Antagonists Revenue by Type (2019-2030)
4.2.1 Global PCSK9 Antagonists Revenue by Type (2019-2024)
4.2.2 Global PCSK9 Antagonists Revenue by Type (2025-2030)
4.2.3 Global PCSK9 Antagonists Revenue Market Share by Type (2019-2030)
4.3 Global PCSK9 Antagonists Price by Type (2019-2030)
5 Segment by Application
5.1 Global PCSK9 Antagonists Sales by Application (2019-2030)
5.1.1 Global PCSK9 Antagonists Sales by Application (2019-2024)
5.1.2 Global PCSK9 Antagonists Sales by Application (2025-2030)
5.1.3 Global PCSK9 Antagonists Sales Market Share by Application (2019-2030)
5.2 Global PCSK9 Antagonists Revenue by Application (2019-2030)
5.2.1 Global PCSK9 Antagonists Revenue by Application (2019-2024)
5.2.2 Global PCSK9 Antagonists Revenue by Application (2025-2030)
5.2.3 Global PCSK9 Antagonists Revenue Market Share by Application (2019-2030)
5.3 Global PCSK9 Antagonists Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi PCSK9 Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi PCSK9 Antagonists Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis PCSK9 Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis PCSK9 Antagonists Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Amgen
6.3.1 Amgen Company Information
6.3.2 Amgen Description and Business Overview
6.3.3 Amgen PCSK9 Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Amgen PCSK9 Antagonists Product Portfolio
6.3.5 Amgen Recent Developments/Updates
6.4 Regeneron Pharmaceuticals
6.4.1 Regeneron Pharmaceuticals Company Information
6.4.2 Regeneron Pharmaceuticals Description and Business Overview
6.4.3 Regeneron Pharmaceuticals PCSK9 Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Regeneron Pharmaceuticals PCSK9 Antagonists Product Portfolio
6.4.5 Regeneron Pharmaceuticals Recent Developments/Updates
6.5 Innovent Biologics
6.5.1 Innovent Biologics Company Information
6.5.2 Innovent Biologics Description and Business Overview
6.5.3 Innovent Biologics PCSK9 Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Innovent Biologics PCSK9 Antagonists Product Portfolio
6.5.5 Innovent Biologics Recent Developments/Updates
6.6 Merck
6.6.1 Merck Company Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck PCSK9 Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merck PCSK9 Antagonists Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Hasten Biopharmaceutical
6.7.1 Hasten Biopharmaceutical Company Information
6.7.2 Hasten Biopharmaceutical Description and Business Overview
6.7.3 Hasten Biopharmaceutical PCSK9 Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Hasten Biopharmaceutical PCSK9 Antagonists Product Portfolio
6.7.5 Hasten Biopharmaceutical Recent Developments/Updates
6.8 Junshi Biosciences
6.8.1 Junshi Biosciences Company Information
6.8.2 Junshi Biosciences Description and Business Overview
6.8.3 Junshi Biosciences PCSK9 Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Junshi Biosciences PCSK9 Antagonists Product Portfolio
6.8.5 Junshi Biosciences Recent Developments/Updates
6.9 Akeso
6.9.1 Akeso Company Information
6.9.2 Akeso Description and Business Overview
6.9.3 Akeso PCSK9 Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Akeso PCSK9 Antagonists Product Portfolio
6.9.5 Akeso Recent Developments/Updates
6.10 Jiangsu Hengrui Pharmaceuticals
6.10.1 Jiangsu Hengrui Pharmaceuticals Company Information
6.10.2 Jiangsu Hengrui Pharmaceuticals Description and Business Overview
6.10.3 Jiangsu Hengrui Pharmaceuticals PCSK9 Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jiangsu Hengrui Pharmaceuticals PCSK9 Antagonists Product Portfolio
6.10.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
6.11 Salubris Pharmaceuticals
6.11.1 Salubris Pharmaceuticals Company Information
6.11.2 Salubris Pharmaceuticals Description and Business Overview
6.11.3 Salubris Pharmaceuticals PCSK9 Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Salubris Pharmaceuticals PCSK9 Antagonists Product Portfolio
6.11.5 Salubris Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PCSK9 Antagonists Industry Chain Analysis
7.2 PCSK9 Antagonists Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PCSK9 Antagonists Production Mode & Process
7.4 PCSK9 Antagonists Sales and Marketing
7.4.1 PCSK9 Antagonists Sales Channels
7.4.2 PCSK9 Antagonists Distributors
7.5 PCSK9 Antagonists Customers
8 PCSK9 Antagonists Market Dynamics
8.1 PCSK9 Antagonists Industry Trends
8.2 PCSK9 Antagonists Market Drivers
8.3 PCSK9 Antagonists Market Challenges
8.4 PCSK9 Antagonists Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
Novartis
Amgen Inc
Regeneron Pharmaceuticals
Innovent Biologics
Merck
Junshi Biosciences
Akeso, Inc.
Jiangsu Hengrui Pharmaceuticals
Salubris Pharmaceuticals
Hasten Biopharmaceutical
List of Tables
 Table 1. Global PCSK9 Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global PCSK9 Antagonists Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global PCSK9 Antagonists Market Competitive Situation by Manufacturers in 2023
 Table 4. Global PCSK9 Antagonists Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global PCSK9 Antagonists Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global PCSK9 Antagonists Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global PCSK9 Antagonists Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market PCSK9 Antagonists Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of PCSK9 Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of PCSK9 Antagonists, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of PCSK9 Antagonists, Product Type & Application
 Table 12. Global Key Manufacturers of PCSK9 Antagonists, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global PCSK9 Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCSK9 Antagonists as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global PCSK9 Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global PCSK9 Antagonists Sales by Region (2019-2024) & (K Units)
 Table 18. Global PCSK9 Antagonists Sales Market Share by Region (2019-2024)
 Table 19. Global PCSK9 Antagonists Sales by Region (2025-2030) & (K Units)
 Table 20. Global PCSK9 Antagonists Sales Market Share by Region (2025-2030)
 Table 21. Global PCSK9 Antagonists Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global PCSK9 Antagonists Revenue Market Share by Region (2019-2024)
 Table 23. Global PCSK9 Antagonists Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global PCSK9 Antagonists Revenue Market Share by Region (2025-2030)
 Table 25. North America PCSK9 Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America PCSK9 Antagonists Sales by Country (2019-2024) & (K Units)
 Table 27. North America PCSK9 Antagonists Sales by Country (2025-2030) & (K Units)
 Table 28. North America PCSK9 Antagonists Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America PCSK9 Antagonists Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe PCSK9 Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe PCSK9 Antagonists Sales by Country (2019-2024) & (K Units)
 Table 32. Europe PCSK9 Antagonists Sales by Country (2025-2030) & (K Units)
 Table 33. Europe PCSK9 Antagonists Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe PCSK9 Antagonists Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific PCSK9 Antagonists Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific PCSK9 Antagonists Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific PCSK9 Antagonists Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific PCSK9 Antagonists Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific PCSK9 Antagonists Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America PCSK9 Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America PCSK9 Antagonists Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America PCSK9 Antagonists Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America PCSK9 Antagonists Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America PCSK9 Antagonists Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa PCSK9 Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa PCSK9 Antagonists Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa PCSK9 Antagonists Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa PCSK9 Antagonists Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa PCSK9 Antagonists Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global PCSK9 Antagonists Sales (K Units) by Type (2019-2024)
 Table 51. Global PCSK9 Antagonists Sales (K Units) by Type (2025-2030)
 Table 52. Global PCSK9 Antagonists Sales Market Share by Type (2019-2024)
 Table 53. Global PCSK9 Antagonists Sales Market Share by Type (2025-2030)
 Table 54. Global PCSK9 Antagonists Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global PCSK9 Antagonists Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global PCSK9 Antagonists Revenue Market Share by Type (2019-2024)
 Table 57. Global PCSK9 Antagonists Revenue Market Share by Type (2025-2030)
 Table 58. Global PCSK9 Antagonists Price (US$/Unit) by Type (2019-2024)
 Table 59. Global PCSK9 Antagonists Price (US$/Unit) by Type (2025-2030)
 Table 60. Global PCSK9 Antagonists Sales (K Units) by Application (2019-2024)
 Table 61. Global PCSK9 Antagonists Sales (K Units) by Application (2025-2030)
 Table 62. Global PCSK9 Antagonists Sales Market Share by Application (2019-2024)
 Table 63. Global PCSK9 Antagonists Sales Market Share by Application (2025-2030)
 Table 64. Global PCSK9 Antagonists Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global PCSK9 Antagonists Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global PCSK9 Antagonists Revenue Market Share by Application (2019-2024)
 Table 67. Global PCSK9 Antagonists Revenue Market Share by Application (2025-2030)
 Table 68. Global PCSK9 Antagonists Price (US$/Unit) by Application (2019-2024)
 Table 69. Global PCSK9 Antagonists Price (US$/Unit) by Application (2025-2030)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Sanofi PCSK9 Antagonists Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Novartis PCSK9 Antagonists Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. Amgen Company Information
 Table 81. Amgen Description and Business Overview
 Table 82. Amgen PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Amgen PCSK9 Antagonists Product
 Table 84. Amgen Recent Developments/Updates
 Table 85. Regeneron Pharmaceuticals Company Information
 Table 86. Regeneron Pharmaceuticals Description and Business Overview
 Table 87. Regeneron Pharmaceuticals PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Regeneron Pharmaceuticals PCSK9 Antagonists Product
 Table 89. Regeneron Pharmaceuticals Recent Developments/Updates
 Table 90. Innovent Biologics Company Information
 Table 91. Innovent Biologics Description and Business Overview
 Table 92. Innovent Biologics PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Innovent Biologics PCSK9 Antagonists Product
 Table 94. Innovent Biologics Recent Developments/Updates
 Table 95. Merck Company Information
 Table 96. Merck Description and Business Overview
 Table 97. Merck PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Merck PCSK9 Antagonists Product
 Table 99. Merck Recent Developments/Updates
 Table 100. Hasten Biopharmaceutical Company Information
 Table 101. Hasten Biopharmaceutical Description and Business Overview
 Table 102. Hasten Biopharmaceutical PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Hasten Biopharmaceutical PCSK9 Antagonists Product
 Table 104. Hasten Biopharmaceutical Recent Developments/Updates
 Table 105. Junshi Biosciences Company Information
 Table 106. Junshi Biosciences Description and Business Overview
 Table 107. Junshi Biosciences PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Junshi Biosciences PCSK9 Antagonists Product
 Table 109. Junshi Biosciences Recent Developments/Updates
 Table 110. Akeso Company Information
 Table 111. Akeso Description and Business Overview
 Table 112. Akeso PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Akeso PCSK9 Antagonists Product
 Table 114. Akeso Recent Developments/Updates
 Table 115. Jiangsu Hengrui Pharmaceuticals Company Information
 Table 116. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
 Table 117. Jiangsu Hengrui Pharmaceuticals PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Jiangsu Hengrui Pharmaceuticals PCSK9 Antagonists Product
 Table 119. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
 Table 120. Salubris Pharmaceuticals Company Information
 Table 121. Salubris Pharmaceuticals Description and Business Overview
 Table 122. Salubris Pharmaceuticals PCSK9 Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Salubris Pharmaceuticals PCSK9 Antagonists Product
 Table 124. Salubris Pharmaceuticals Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. PCSK9 Antagonists Distributors List
 Table 128. PCSK9 Antagonists Customers List
 Table 129. PCSK9 Antagonists Market Trends
 Table 130. PCSK9 Antagonists Market Drivers
 Table 131. PCSK9 Antagonists Market Challenges
 Table 132. PCSK9 Antagonists Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of PCSK9 Antagonists
 Figure 2. Global PCSK9 Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global PCSK9 Antagonists Market Share by Type: 2023 & 2030
 Figure 4. Monoclonal Antibody Product Picture
 Figure 5. siRNA Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global PCSK9 Antagonists Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global PCSK9 Antagonists Market Share by Application: 2023 & 2030
 Figure 9. Hypercholesterolemia
 Figure 10. Atherosclerotic Cardiovascular Disease
 Figure 11. Others
 Figure 12. Global PCSK9 Antagonists Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global PCSK9 Antagonists Market Size (2019-2030) & (US$ Million)
 Figure 14. Global PCSK9 Antagonists Sales (2019-2030) & (K Units)
 Figure 15. Global PCSK9 Antagonists Average Price (US$/Unit) & (2019-2030)
 Figure 16. PCSK9 Antagonists Report Years Considered
 Figure 17. PCSK9 Antagonists Sales Share by Manufacturers in 2023
 Figure 18. Global PCSK9 Antagonists Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest PCSK9 Antagonists Players: Market Share by Revenue in PCSK9 Antagonists in 2023
 Figure 20. PCSK9 Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global PCSK9 Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America PCSK9 Antagonists Sales Market Share by Country (2019-2030)
 Figure 23. North America PCSK9 Antagonists Revenue Market Share by Country (2019-2030)
 Figure 24. United States PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe PCSK9 Antagonists Sales Market Share by Country (2019-2030)
 Figure 27. Europe PCSK9 Antagonists Revenue Market Share by Country (2019-2030)
 Figure 28. Germany PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific PCSK9 Antagonists Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific PCSK9 Antagonists Revenue Market Share by Region (2019-2030)
 Figure 35. China PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America PCSK9 Antagonists Sales Market Share by Country (2019-2030)
 Figure 43. Mexico PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa PCSK9 Antagonists Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa PCSK9 Antagonists Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE PCSK9 Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of PCSK9 Antagonists by Type (2019-2030)
 Figure 53. Global Revenue Market Share of PCSK9 Antagonists by Type (2019-2030)
 Figure 54. Global PCSK9 Antagonists Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of PCSK9 Antagonists by Application (2019-2030)
 Figure 56. Global Revenue Market Share of PCSK9 Antagonists by Application (2019-2030)
 Figure 57. Global PCSK9 Antagonists Price (US$/Unit) by Application (2019-2030)
 Figure 58. PCSK9 Antagonists Value Chain
 Figure 59. PCSK9 Antagonists Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global PCSK9 Targeted Drugs Market Research Report 2024
Global Monoclonal Antibodies for Primary Hypercholesterolemia Market Research Report 2024
Global Cholesterol lowering Statins Market Research Report 2024
Global Cholesterol Lowering Biologic Drugs Market Research Report 2024
Global Nonstatin Cholesterol Medications Market Research Report 2024
Global Cholesterol fighting Vaccine Market Research Report 2024
Global Alirocumab Market Research Report 2024
Global Cholesterol Vaccines Market Research Report 2024
Global Cholesterol Absorption Inhibitors Market Research Report 2024
Global Ezetimibe Tablets Market Research Report 2024
Global Anti PCSK9 Monoclonal Antibody Market Insights Forecast to 2030
Antihyperlipidemic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PCSK9 targeted Therapy Market Research Report 2025
Global Cholesterol Lowering Supplements Market Research Report 2024
Global GLP 1 Receptor Antagonist Market Research Report 2024
Global Statins Market Research Report 2024
Ezetimibe and Simvastatin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Evacetrapib Market Research Report 2024
Global Blood Lipid Regulating Drugs Market Research Report 2024
Global Complex Dyslipidemia Treatment Market Research Report 2025

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions